Christianna Silva
-
Pirette McKamey, the principal at Mission High School in San Francisco, says anti-racist education "makes you want to keep growing and changing and doing better by your students."
-
Travis Bristol, an assistant professor of education at the University of California at Berkeley, explains how teacher training and the presence of Black teachers can help reshape education.
-
Florida and Texas report their biggest daily rise in new confirmed cases of COVID-19 in the past few days as deaths in the U.S. continue to rise.
-
Imara Jones, the founder of TransLash Media, talks about Black trans issues in the wake of LGBTQ Pride intersecting with protests against police violence.
-
NPR's Noel King speaks with Christian Picciolini, a reformed neo-Nazi skinhead, about what extremists may have heard when the president retweeted a video of an alleged supporter yelling "white power."
-
Dr. Joseph Betancourt of Massachusetts General Hospital says a "perfect storm" of factors is causing the coronavirus to hit the nation's Latinx population especially hard.
-
Lt. Gov. Geoff Duncan discusses three crises gripping his state: rising cases of COVID-19, voting issues during a recent primary, and the killings of two Black men, Ahmaud Arbery and Rayshard Brooks.
-
Erika Lautenbach, director of the Whatcom County Health Department in Washington state, says protests against police violence aren't among the catalysts for the spread of COVID-19.
-
Bill Lester, one of only seven Black drivers to race in NASCAR's top-tier cup series, says he wanted the flag gone when he raced more than a decade ago. "The country was not ready to listen," he says.
-
After three months of restrictions, nursing homes in the state are beginning to allow visitors again. Families are learning that the experience of reopening won't be the same for everyone.
-
Tom Petty's family issued a cease-and-desist notice to the Trump campaign after the president played "I Won't Back Down" at his rally in Tulsa, Okla.
-
The NIH said that while the anti-malarial drug did not cause harm to patients in the study, testing showed little evidence that it would benefit patients hospitalized with COVID-19.